World's Best Scientists 2026 revealed!
James B. Leverenz

James B. Leverenz

D-Index & Metrics

Neuroscience

D-Index
107
Citations
51804
World Ranking
600
National Ranking
340

Overview

James B. Leverenz is affiliated with the Cleveland Clinic in the United States, focusing their research primarily within the field of Medicine. Their work spans several specialized subfields, including Neurology, Psychiatry and Mental Health, Physiology, Molecular Biology, and Immunology.

The core topics addressed in their research include:

  • Alzheimer's disease research and treatments
  • Dementia and Cognitive Impairment Research
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Parkinson's Disease Mechanisms and Treatments
  • Bioinformatics and Genomic Networks
  • Tryptophan and brain disorders
  • Inflammation biomarkers and pathways

Leverenz has contributed to numerous publications in notable venues. Their frequent publication outlets include:

  • Alzheimer's & Dementia
  • Neurology
  • Alzheimer's Research & Therapy
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Alzheimer's Disease

Leverenz has collaborated extensively with several co-authors, including:

  • Jagan A. Pillai
  • Lynn M. Bekris
  • Feixiong Cheng
  • Andrew A. Pieper
  • Jeffrey L. Cummings

Their recent published papers reflect ongoing engagement with neurodegenerative disorders and cognitive conditions. Notable recent works include:

  • Research criteria for the diagnosis of prodromal dementia with Lewy bodies, 2020, Neurology
  • Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium, 2020, Newcastle University ePrints (Newcastle University)
  • LATE-NC staging in routine neuropathologic diagnosis: an update, 2022, Acta Neuropathologica
  • Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment, 2021, Alzheimer's Research & Therapy
  • Mediterranean and Western diet effects on Alzheimer's disease biomarkers, cerebral perfusion, and cognition in mid-life: A randomized trial, 2021, Alzheimer's & Dementia

Best Publications

  • Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium

    Ian G. McKeith;Bradley F. Boeve;Dennis W. DIckson;Glenda Halliday

  • Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature

    Peter T Nelson;Irina Alafuzoff;Eileen H Bigio;Constantin Bouras

  • Analysis of shared heritability in common disorders of the brain

    Verneri Anttila;Verneri Anttila;Brendan Bulik-Sullivan;Brendan Bulik-Sullivan;Hilary K. Finucane;Raymond K. Walters;Raymond K. Walters

  • The Parkinson Progression Marker Initiative (PPMI)

    Kenneth Marek;Danna Jennings;Shirley Lasch;Andrew Siderowf

  • Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment

    Suzanne Craft;Laura D. Baker;Thomas J. Montine;Satoshi Minoshima

  • Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria.

    Dennis W Dickson;Heiko Braak;John E Duda;Charles Duyckaerts

  • Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

    Rebecca Sims;Sven J. Van Der Lee;Adam C. Naj;Céline Bellenguez;Céline Bellenguez

  • TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis

    Vivianna M. Van Deerlin;James B. Leverenz;James B. Leverenz;Lynn M. Bekris;Thomas D. Bird;Thomas D. Bird

  • DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease

    Zhen Hong;Min Shi;Kathryn A. Chung;Joseph F. Quinn

  • Research criteria for the diagnosis of prodromal dementia with Lewy bodies

    Ian G. McKeith;Tanis J. Ferman;Alan J. Thomas;Frédéric Blanc

  • TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer’s disease mouse models

    Taylor R. Jay;Crystal M Miller;Paul J Cheng;Leah C Graham

  • DLB and PDD boundary issues: Diagnosis, treatment, molecular pathology, and biomarkers

    C. F. Lippa;J. E. Duda;M. Grossman;H. I. Hurtig

  • Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study

    Osama Sabri;Marwan N. Sabbagh;John Seibyl;Henryk Barthel

  • Neuropathologic substrates of Parkinson disease dementia.

    David J. Irwin;Matthew T. White;Jon B. Toledo;Sharon X. Xie

  • Neuropathological and Genetic Correlates of Survival and Dementia Onset in Synucleinopathies: A Retrospective Analysis

    David J Irwin;Murray Grossman;Daniel Weintraub;Daniel Weintraub;Howard I Hurtig

  • Clinico-Neuropathological Correlation of Alzheimer's Disease in a Community-Based Case Series

    Alfredo Lim;Debby Tsuang;Walter Kukull;David Nochlin

  • Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases.

    Hanae Nakashima-Yasuda;Kunihiro Uryu;John Robinson;Sharon X. Xie

  • Pathological correlates of dementia in a longitudinal, population-based sample of aging

    Joshua A. Sonnen;Eric B. Larson;Paul K. Crane;Sebastien Haneuse

  • Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression.

    Min Shi;Joshua Bradner;Aneeka M. Hancock;Kathryn A. Chung

  • Association of Traumatic Brain Injury With Late-Life Neurodegenerative Conditions and Neuropathologic Findings

    Paul K. Crane;Laura E. Gibbons;Kristen Dams-O’Connor;Emily Trittschuh

  • Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders

    Fadi Abdi;Joseph F. Quinn;Joseph Jankovic;Martin McIntosh

Frequent Co-Authors

Elaine R. Peskind
Elaine R. Peskind University of Washington
Thomas D. Bird
Thomas D. Bird University of Washington
Gerard D. Schellenberg
Gerard D. Schellenberg University of Pennsylvania
John Q. Trojanowski
John Q. Trojanowski University of Pennsylvania
Jeffrey Kaye
Jeffrey Kaye Oregon Health & Science University
Daniel Weintraub
Daniel Weintraub University of Pennsylvania
Chang En Yu
Chang En Yu University of Washington
Stephen M. Rao
Stephen M. Rao Cleveland Clinic
Irene Litvan
Irene Litvan University of California, San Diego
Eliezer Masliah
Eliezer Masliah National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online education can open up new doors for students interested in neuroscience and related fields. Many aspiring professionals now consider stacking their credentials through online certificate programs that pay well, allowing them to build specialized skills and improve their employability—often in less time than it takes to earn a traditional degree.

For those seeking a streamlined academic path, looking into the easiest degree to get online can help accelerate entry into the workforce and reduce educational expenses. Complementing a neuroscience background with interdisciplinary training, such as behavioral health or social work, can also be beneficial.

Notably, related fields such as mental health and behavioral analysis offer in-demand online programs. Professionals interested in social impact may consider msw programs online, focusing on social work and counseling. Meanwhile, aspiring specialists in applied behavioral analysis can look into the bcba masters programs to enhance their career prospects.

By combining neuroscience with these related degrees and certifications, students can unlock a range of career pathways and meet today’s diverse workforce needs.

Best Scientists Citing James B. Leverenz

Trending Scientists